NENS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial (NCT07077551) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-04-22 |
Track NENS automatically
Every clearance here is in the API, with alerts when new ones post.